BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26918035)

  • 41. Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer.
    Leyssens C; Verlinden L; Verstuyf A
    Endocr Relat Cancer; 2013 Apr; 20(2):R31-47. PubMed ID: 23319494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic Variations in VDR could Modulate the Efficacy of Vitamin D3 Supplementation on Inflammatory Markers and Total Antioxidant Capacity among Breast Cancer Women: A Randomized Double Blind Controlled Trial.
    Mohseni H; Amani R; Hosseini SA; Ekrami A; Ahmadzadeh A; Latifi SM
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2065-2072. PubMed ID: 31350967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D Supplementation Trials Aimed at Reducing Mortality Have Much Higher Power When Focusing on People with Low Serum 25-Hydroxyvitamin D Concentrations.
    Brenner H; Jansen L; Saum KU; Holleczek B; Schöttker B
    J Nutr; 2017 Jul; 147(7):1325-1333. PubMed ID: 28539415
    [No Abstract]   [Full Text] [Related]  

  • 45. The D-Health Trial: A randomized trial of vitamin D for prevention of mortality and cancer.
    Neale RE; Armstrong BK; Baxter C; Duarte Romero B; Ebeling P; English DR; Kimlin MG; McLeod DS; O Connell RL; van der Pols JC; Venn AJ; Webb PM; Whiteman DC; Wockner L
    Contemp Clin Trials; 2016 May; 48():83-90. PubMed ID: 27086041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
    Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL
    J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women.
    Chandler PD; Buring JE; Manson JE; Giovannucci EL; Moorthy MV; Zhang S; Lee IM; Lin JH
    Cancer Prev Res (Phila); 2015 Aug; 8(8):675-82. PubMed ID: 25813525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Effect of High-Dose Postpartum Maternal Vitamin D Supplementation Alone Compared with Maternal Plus Infant Vitamin D Supplementation in Breastfeeding Infants in a High-Risk Population. A Randomized Controlled Trial.
    Dawodu A; Salameh KM; Al-Janahi NS; Bener A; Elkum N
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31319554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology of vitamin D and colorectal cancer: casual or causal link?
    Giovannucci E
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):349-54. PubMed ID: 20398758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemoprevention of bladder cancer.
    Kamat AM; Lamm DL
    Urol Clin North Am; 2002 Feb; 29(1):157-68. PubMed ID: 12109342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin D and prevention of breast cancer: pooled analysis.
    Garland CF; Gorham ED; Mohr SB; Grant WB; Giovannucci EL; Lipkin M; Newmark H; Holick MF; Garland FC
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):708-11. PubMed ID: 17368188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitamin d: are we ready to supplement for breast cancer prevention and treatment?
    Crew KD
    ISRN Oncol; 2013; 2013():483687. PubMed ID: 23533810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality.
    Grant WB
    Dermatoendocrinol; 2009 Jan; 1(1):17-24. PubMed ID: 20046584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dr. Frank caldwell garland, june 20, 1950-august 17, 2010.
    Grant WB; Gorham ED
    Dermatoendocrinol; 2010 Apr; 2(2):46-9. PubMed ID: 21547096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature.
    Gupta D; Vashi PG; Trukova K; Lis CG; Lammersfeld CA
    Exp Ther Med; 2011 Mar; 2(2):181-193. PubMed ID: 22977487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emerging role of vitamin D in colorectal cancer.
    Kang W; Lee S; Jeon E; Yun YR; Kim KH; Jang JH
    World J Gastrointest Oncol; 2011 Aug; 3(8):123-7. PubMed ID: 22007275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin D and Breast Cancer: Latest Evidence and Future Steps.
    Atoum M; Alzoughool F
    Breast Cancer (Auckl); 2017; 11():1178223417749816. PubMed ID: 29434472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Vitamin D in Colorectal Cancer: A Holistic Approach and Review of the Clinical Utility.
    Javed M; Althwanay A; Ahsan F; Oliveri F; Goud HK; Mehkari Z; Mohammed L; Rutkofsky IH
    Cureus; 2020 Sep; 12(9):e10734. PubMed ID: 33145139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer.
    Raman M; Milestone AN; Walters JR; Hart AL; Ghosh S
    Therap Adv Gastroenterol; 2011 Jan; 4(1):49-62. PubMed ID: 21317994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vitamin D and urological cancers.
    Krajewski W; Dzięgała M; Kołodziej A; Dembowski J; Zdrojowy R
    Cent European J Urol; 2016; 69(2):139-47. PubMed ID: 27551550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.